Autoimmune Diseases  >>  Victoza (liraglutide)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Victoza (liraglutide) / Novo Nordisk
NCT01206101 / 2009-013090-18: Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation

Terminated
2
3
US, Canada, Europe
liraglutide, placebo
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1
06/13
06/13
NCT01755416: Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting

Completed
2
18
US
Closed loop with sensor and Insulin, Novolog, Closed loop with sensor, Insulin and Liraglutide, Victoza
Albert Einstein College of Medicine, Medtronic
Type 1 Diabetes
01/15
01/15
NCT01782261 / 2011-006300-12: Incretin Effect on the Immunological Phenotype

Completed
2
15
Europe
Liraglutide, Victoza, Saxagliptin, Onglyza
Medical University of Graz
Type 1 Diabetes
02/15
02/15
NCT02408705: Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects

Completed
2
14
Europe
Liraglutide, Victoza, Placebo, Mixed Meal Tolerance Test with paracetamol, MMTT
Medical University of Graz, Novo Nordisk A/S
Type 1 Diabetes Mellitus
05/16
05/16

Download Options